These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6960593)

  • 1. Prevention of EAE with monoclonal anti-I-A antibodies.
    Steinman L; Rosenbaum JT; Sriram S; McDevitt HO
    Trans Am Neurol Assoc; 1981; 106():237-8. PubMed ID: 6960593
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoantibody-promoting factor producing hybridoma and suppressive monoclonal anti-Ia antibody (HAK-75)].
    Sawada S; Shimada H; Karasaki M; Amaki K
    Nihon Rinsho; 1985 Jan; 43(1):177-80. PubMed ID: 3857364
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-class II antibody treatment in autoimmune diseases.
    Boitard C
    Immunol Ser; 1993; 59():279-93. PubMed ID: 8461393
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicity of major histocompatibility complex class II specific monoclonal antibodies: audietur et altera pars.
    Toral IJ; Vidović D
    Croat Med J; 1999 Sep; 40(3):353-6. PubMed ID: 10411962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-V beta TcR monoclonal antibodies identify and can activate anergic T cells from mice rendered neonatally tolerant of class II alloantigens.
    Levy RB; Jones M; Streilein JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):360-1. PubMed ID: 8438335
    [No Abstract]   [Full Text] [Related]  

  • 6. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex class II expression is required for posttransplant immunological but not hemopoietic reconstitution in mice.
    Huss R; Beckham C; Storb R; Deeg HJ
    Transplantation; 1994 Dec; 58(12):1366-71. PubMed ID: 7809930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells.
    Vidal K; Samarut C; Magaud JP; Revillard JP; Kaiserlian D
    J Immunol; 1993 Nov; 151(9):4642-50. PubMed ID: 8409425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface expression of alien hybrid IE/C antigens on the reticulum cell sarcoma of SJL/J mice.
    Bonavida B; Wilbur SM; Marelli O
    Transplant Proc; 1981 Dec; 13(4):1833-6. PubMed ID: 7036479
    [No Abstract]   [Full Text] [Related]  

  • 13. Early evaluation of Ia monoclonal antibodies in prolonging non-human primate skin allograft survival.
    Chatterjee SN; Billings R; Bernoco D; Terasaki P
    Proc Eur Dial Transplant Assoc; 1981; 18():362-6. PubMed ID: 7036155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of immunization with lipid associated polysaccharide antigen and anti CD-2 antibodies on class II MHC expression and cellular immune response in BALB/C mice infected with Leishmania donovani.
    Bimal S; Bagchi AK; Das V; Sinha PK; Lal CS; Ranjan A; Gupta AK; Kar SK
    Indian J Exp Biol; 2001 Sep; 39(9):878-82. PubMed ID: 11831368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal anti-Ia antibody therapy in animal models of autoimmune disease.
    McDevitt HO; Perry R; Steinman LA
    Ciba Found Symp; 1987; 129():184-93. PubMed ID: 3315501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen.
    Maeda H; Ogoshi S; Fujimoto S
    Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685
    [No Abstract]   [Full Text] [Related]  

  • 17. Ontogeny of tolerogen-responsive lymphocytes following neonatal inoculation of class II disparate semiallogeneic cells.
    Socarras S; Matriano J; Streilein JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):354-6. PubMed ID: 8438332
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round.
    Bemelman F; Yong SL; Tissingh R; Schellekens P; ten Berge I
    Transpl Int; 2005 Apr; 18(4):423-8. PubMed ID: 15773962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment of islets with anti-Ia monoclonal antibodies.
    Morrow CE; Najarian JS; Sutherland DE; Bach FH; Steffes MW
    Transplantation; 1985 Jan; 39(1):111. PubMed ID: 3917586
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of the adjuvant-independent antibody response to immunotargeting. Target structure dependence, isotype distribution, and induction of long term memory.
    Skea DL; Barber BH
    J Immunol; 1993 Oct; 151(7):3557-68. PubMed ID: 8376792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.